Nanomedicine platform targeting kidney diseases through size/charge optimization. Our nanotherapeutics-peptide micelles revolutionizes highly safe drug and gene delivery by targeting the disease sites and minimizing off-target side effect.
$7M Cap SAFE with 20% discount. SH committed $500K, via StoryHouse Fund II, at a $7M valuation, in a $500K round, alongside TechStars.
**Silver Spur / Monthly Catchup Zoom / 02JUNE2026** L & E / K & M Team Updates & Hiring • E joining as full-time R&D lead in August (he? Is currently a post-doc in Eun Ji’s lab and is running the Sponsored Research projects for SS in her lab – so good continuity / extension of her lab here) •...
Source: Meeting Notes recviIvwaTMwXIQkS
May 22, 2026 Zoom - David Katz & Matthew Estes Granola Summary Notes below with modest edits. Summary: Even though the first call with Silver Spur did not go well, David is still interested and willing to have a second call with Eunji one on one to discuss the science in more detail to see whether...
Source: Meeting Notes recCHXC9baO5Qf9jB
19MAY2026 Zoom: Keith & Matthew with Eunji and Laura of Silver Spur David Katz Introduction Debrief • Both sides agreed there was miscommunication about meeting purpose and strategy for the Katz call, but SH being generous here, Laura knew what call was to be about • Matthew's guidance for the...
Source: Meeting Notes recptdPuI507GDrpz
2026-05-28: Reference involving Eunji Chung. May 22, 2026 Zoom - David Katz & Matthew Estes Granola Summary Notes below with modest edits. Summary: Even though the first call with Silver Spur did not go well, David is still interested and willing to have a second c...
2026-05-19: Reference involving Eunji Chung, Laura Bae. 19MAY2026 Zoom: Keith & Matthew with Eunji and Laura of Silver Spur David Katz Introduction Debrief • Both sides agreed there was miscommunication about meeting purpose and strategy for the Katz call, but SH being genero...